SYDNEY LAFRENIER: Open Payments
NPI 1548083819 · OLYMPIA FIELDS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 43 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 21 | $230 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| HEARTFLOW, INC. | 2 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $60 |
| Novo Nordisk Inc | 3 | $50 |
| Corcept Therapeutics | 1 | $23 |
| Almatica Pharma LLC | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
Products named: MOUNJARO, JARDIANCE, FFRct, BREZTRI, ELIQUIS, CAMZYOS, AIRSUPRA, Korlym.
Industry payments across IL — which companies pay providers there.
